{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T13:07:50Z","timestamp":1784293670367,"version":"3.55.0"},"reference-count":83,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007270","name":"University of Michigan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011306","name":"American Society for Investigative Pathology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011306","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Gastroenterol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Aquamin, a multi-mineral product derived from fossilized red marine algae, has been shown to improve colon barrier structure and function. Mesalamine is commonly used as maintenance therapy for patients with mild-to-moderate ulcerative colitis (UC) or those in remission. Our long-term aim is to evaluate if Aquamin can be part of a UC maintenance regimen, examining potential complementary efficacy or synergy with Mesalamine, as well as any possible drug interactions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Human colon organoids were maintained under controlled conditions or exposed to a pro-inflammatory stimulus to mimic the environment in mild-to-moderate UC. Organoids were treated with Aquamin alone, Mesalamine alone, or the two agents in combination for 14 days. At the end of the treatment period, proteomic analysis was conducted to evaluate protein changes induced by the two agents (individually and in combination).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Colon organoids treated with Aquamin or Mesalamine exhibited distinct protein expression profiles. Aquamin enhanced the expression of colon barrier proteins (e.g., cadherin-17 and desmoglein-2). Mesalamine by itself had minimal impact on these moieties; when present with Aquamin, it did not alter Aquamin\u2019s response. By itself, treatment with Mesalamine alone resulted in up-regulation of basement membrane proteins; the combination of Aquamin and Mesalamine was more effective than either alone. In contrast to these results, Mesalamine up-regulated numerous proteins directly related to inflammation including members of the complement and clotting\/fibrinolytic cascades. These were down-regulated with Aquamin. When the two agents were utilized in combination, changes in the expression of inflammation-related proteins resembled the profile seen with Mesalamine alone more than the profile obtained with Aquamin. Of interest, the presence of a pro-inflammatory stimulus further highlighted the unique responses to the two interventions, with Mesalamine aligning more closely with the pro-inflammatory stimulus in its effect on the expression of inflammation-associated proteins.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The data presented here suggest that the induction of barrier proteins by Aquamin would not be counteracted by the concomitant presence of Mesalamine. The current studies also found no evidence to suggest that the presence of Aquamin would interfere with the capacity of Mesalamine to alter the expression of proteins that are part of the anti-inflammatory shield.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fgstr.2025.1592669","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T11:49:06Z","timestamp":1751456946000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Proteomic profile of human colon organoids: effects of a multi-mineral intervention alone and in the presence of pro-inflammatory and anti-inflammatory treatments"],"prefix":"10.3389","volume":"4","author":[{"given":"Muhammad Nadeem","family":"Aslam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon D.","family":"McClintock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Moraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniyal M.","family":"Nadeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Harber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Varani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1102942","article-title":"Ulcerative colitis","volume":"365","author":"Danese","year":"2011","journal-title":"New Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00966-2","article-title":"Ulcerative colitis","volume":"402","author":"Le Berre","year":"2023","journal-title":"Lancet (London England)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60150-0","article-title":"Ulcerative colitis","volume":"380","author":"Ord\u00e1s","year":"2012","journal-title":"Lancet (London England)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nature06005","article-title":"Unravelling the pathogenesis of inflammatory bowel disease","volume":"448","author":"Xavier","year":"2007","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.26279","article-title":"The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study","volume":"121","author":"Faubion","year":"2001","journal-title":"Gastroenterology"},{"key":"B6","article-title":"Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study Group","volume":"88","author":"Hanauer","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.5009\/gnl14226","article-title":"Current and emerging biologics for ulcerative colitis","volume":"9","author":"Park","year":"2015","journal-title":"Gut Liver"},{"key":"B8","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJMoa1215734","article-title":"& GEMINI 1 Study Group. Vedolizumab as induction and maintenance therapy for ulcerative colitis","volume":"369","author":"Feagan","year":"2013","journal-title":"New Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(21)00377-0","article-title":"Efficacy and safety of biologics and small molecule drugs for patients with moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis","volume":"7","author":"Lasa","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0126-x","article-title":"Mechanisms regulating intestinal barrier integrity and its pathological implications","volume":"50","author":"Chelakkot","year":"2018","journal-title":"Exp Mol Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2016.128","article-title":"Gut permeability and mucosal inflammation: bad, good or context dependent","volume":"10","author":"Ahmad","year":"2017","journal-title":"Mucosal Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/proteomes6020017","article-title":"Molecular pathophysiology of epithelial barrier dysfunction in inflammatory bowel diseases","volume":"6","author":"Lee","year":"2018","journal-title":"Proteomes"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20539","article-title":"Intestinal barrier dysfunction in inflammatory bowel diseases","volume":"15","author":"McGuckin","year":"2009","journal-title":"Inflammatory Bowel Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21403","article-title":"Importance of disrupted intestinal barrier in inflammatory bowel diseases","volume":"17","author":"Salim","year":"2011","journal-title":"Inflammatory Bowel Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-317571","article-title":"Structural weakening of the colonic mucus barrier is an early event in ulcerative colitis pathogenesis","volume":"68","author":"van der Post","year":"2019","journal-title":"Gut"},{"key":"B16","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1053\/j.gastro.2017.05.056","article-title":"Impaired intestinal permeability contributes to ongoing bowel symptoms in patients with inflammatory bowel disease and mucosal healing","volume":"153","author":"Chang","year":"2017","journal-title":"Gastroenterology"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-304066","article-title":"Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation","volume":"63","author":"Vivinus-N\u00e9bot","year":"2014","journal-title":"Gut"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-331579","article-title":"Opening the doors of precision medicine: novel tools to assess intestinal barrier in inflammatory bowel disease and colitis-associated neoplasia","volume":"73","author":"Iacucci","year":"2024","journal-title":"Gut"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2015.40","article-title":"Intestinal barrier loss as a critical pathogenic link between inflammatory bowel disease and graft-versus-host disease","volume":"8","author":"Nalle","year":"2015","journal-title":"Mucosal Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e0215122","DOI":"10.1371\/journal.pone.0215122","article-title":"Calcium-induced differentiation in normal human colonoid cultures: Cell-cell\/cell-matrix adhesion, barrier formation and tissue integrity","volume":"14","author":"Attili","year":"2019","journal-title":"PloS One"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e0222058","DOI":"10.1371\/journal.pone.0222058","article-title":"Differentiation of human colon tissue in culture: Effects of calcium on trans-epithelial electrical resistance and tissue cohesive properties","volume":"15","author":"McClintock","year":"2020","journal-title":"PloS One"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.838975","article-title":"Cell-matrix interactions contribute to barrier function in human colon organoids","volume":"9","author":"Varani","year":"2022","journal-title":"Front Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1132905","article-title":"A multi-mineral intervention to counter pro-inflammatory activity and to improve the barrier in human colon organoids","volume":"11","author":"Varani","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.577221","article-title":"Ulcerative colitis-derived colonoid culture: A multi-mineral-approach to improve barrier protein expression","volume":"8","author":"Aslam","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/nu13030939","article-title":"A multi-mineral intervention to modulate colonic mucosal protein profile: results from a 90-day trial in human subjects","volume":"13","author":"Aslam","year":"2021","journal-title":"Nutrients"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1101\/2025.02.17.25322298","article-title":"A multi-mineral intervention to improve disease-related and mechanistic biomarkers in ulcerative colitis patients","author":"Aslam","year":"2025","journal-title":"medRxiv"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.4989","article-title":"A mineral extract from red algae ameliorates chronic spontaneous colitis in IL-10 deficient mice in a mouse strain dependent manner","volume":"28","author":"Aviello","year":"2014","journal-title":"Phytother Res: PTR"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1177\/1534735409360360","article-title":"A mineral-rich red algae extract inhibits polyp formation and inflammation in the gastrointestinal tract of mice on a high-fat diet","volume":"9","author":"Aslam","year":"2010","journal-title":"Integr Cancer Therapies"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1080\/01635581.2012.713160","article-title":"A multimineral natural product from red marine algae reduces colon polyp formation in C57BL\/6 mice","volume":"64","author":"Aslam","year":"2012","journal-title":"Nutr Cancer"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1515\/botm.1970.13.2.100","article-title":"Studies on the Maerl Species Phymatolithon calcareum (Pallas) nov. comb. and Lithothamnium coralloides Crouan in the Ria de Vigo","volume":"13","author":"Adey","year":"1970","journal-title":"Botanica Marina"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.2001.281.4.G1044","article-title":"Mesalamine induces manganese superoxide dismutase in rat intestinal epithelial cell lines and in vivo","volume":"281","author":"Valentine","year":"2001","journal-title":"Am J Physiol Gastrointestinal Liver Physiol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1080\/00365520510015854","article-title":"Mesalamine promotes intestinal epithelial wound healing in vitro through a TGF-beta-independent mechanism","volume":"40","author":"Baumgart","year":"2005","journal-title":"Scandinavian J Gastroenterol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1039\/c6fo01592a","article-title":"Yogurt inhibits intestinal barrier dysfunction in Caco-2 cells by increasing tight junctions","volume":"8","author":"Putt","year":"2017","journal-title":"Food Funct"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2013.153","article-title":"In vitro expansion and genetic modification of gastrointestinal stem cells in spheroid culture","volume":"8","author":"Miyoshi","year":"2013","journal-title":"Nat Protoc"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1021\/ac502040v","article-title":"MultiNotch MS3 enables accurate, sensitive, and multiplexed detection of differential expression across cancer cell line proteomes","volume":"86","author":"McAlister","year":"2014","journal-title":"Analytical Chem"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/s0960-9822(01)00346-3","article-title":"Cadherin function: breaking the barrier","volume":"11","author":"Ishii","year":"2001","journal-title":"Curr Biol: CB"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2021.151183","article-title":"Revisiting the multiple roles of T-cadherin in health and disease","volume":"100","author":"Rubina","year":"2021","journal-title":"Eur J Cell Biol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.230045","article-title":"Protocadherin-12 cleavage is a regulated process mediated by ADAM10 protein: evidence of shedding up-regulation in pre-eclampsia","volume":"286","author":"Bouillot","year":"2011","journal-title":"J Biol Chem"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158101","article-title":"Protocadherin gamma C3 (PCDHGC3) is strongly expressed in glioblastoma and its high expression is associated with longer progression-free survival of patients","volume":"23","author":"Feldheim","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112995","article-title":"ZG16 impacts gut microbiota-associated intestinal inflammation and pulmonary mucosal function through bacterial metabolites","volume":"141","author":"Chen","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s10863-020-09850-8","article-title":"CADM1 enhances intestinal barrier function in a rat model of mild inflammatory bowel disease by inhibiting the STAT3 signaling pathway","volume":"52","author":"Sun","year":"2020","journal-title":"J Bioenergetics Biomembranes"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10030727","article-title":"Evaluation of AIF-1 (Allograft inflammatory factor-1) as a biomarker of crohn\u2019s disease severity","volume":"10","author":"Guijarro","year":"2022","journal-title":"Biomedicines"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2020.10.011","article-title":"The metabolic underpinnings of ferroptosis","volume":"32","author":"Zheng","year":"2020","journal-title":"Cell Metab"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.07.015","article-title":"Iron uptake via DMT1 integrates cell cycle with JAK-STAT3 signaling to promote colorectal tumorigenesis","volume":"24","author":"Xue","year":"2016","journal-title":"Cell Metab"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s12011-011-9316-2","article-title":"A multi-mineral natural product inhibits liver tumor formation in C57BL\/6 mice","volume":"147","author":"Aslam","year":"2012","journal-title":"Biol Trace Element Res"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.859292","article-title":"Liver protein expression in NASH mice on a high-fat diet: response to multi-mineral intervention","volume":"9","author":"Varani","year":"2022","journal-title":"Front Nutr"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.12.009","article-title":"AGA clinical practice guidelines on the management of mild-to-moderate ulcerative colitis","volume":"156","author":"Ko","year":"2019","journal-title":"Gastroenterology"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/s11626-020-00534-6","article-title":"Organoid culture to study epithelial cell differentiation and barrier formation in the colon: bridging the gap between monolayer cell culture and human subject research","volume":"57","author":"Varani","year":"2021","journal-title":"Vitro Cell Dev Biol Anim"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.1038\/s41598-019-39401-0","article-title":"Mesalamine and azathioprine modulate junctional complexes and restore epithelial barrier function in intestinal inflammation","volume":"9","author":"Khare","year":"2019","journal-title":"Sci Rep"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2011.10.013","article-title":"Aminosalicylates. Best practice & research","volume":"25","author":"Campregher","year":"2011","journal-title":"Clin Gastroenterol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000544.pub4","article-title":"Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis","volume":"5","author":"Wang","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(81)90594-1","article-title":"Enhanced thromboxane A2 and prostacyclin production by cultured rectal mucosa in ulcerative colitis and its inhibition by steroids and sulfasalazine","volume":"81","author":"Ligumsky","year":"1981","journal-title":"Gastroenterology"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/BF01314051","article-title":"Modulation of human colonic arachidonic acid metabolism by sulfasalazine","volume":"30","author":"Hawkey","year":"1985","journal-title":"Digestive Dis Sci"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.01.051","article-title":"Different sensitivity of lamina propria T-cell subsets to nitric oxide-induced apoptosis explains immunomodulatory activity of a nitric oxide-releasing derivative of mesalamine in rodent colitis","volume":"128","author":"Santucci","year":"2005","journal-title":"Gastroenterology"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(90)90329-y","article-title":"Clinical evidence supporting the radical scavenger mechanism of 5-aminosalicylic acid","author":"Ahnfelt-R\u00f8nne","year":"1990","journal-title":"Gastroenterol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1179\/135100010X12826446921707","article-title":"Scavenging of reactive oxygen and nitrogen species by the prodrug sulfasalazine and its metabolites 5-aminosalicylic acid and sulfapyridine","volume":"15","author":"Couto","year":"2010","journal-title":"Redox Report: Commun Free Radical Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.03360.x","article-title":"Mesalazine inhibits activation of transcription factor NF-kappaB in inflamed mucosa of patients with ulcerative colitis","volume":"95","author":"Bantel","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/s0016-5085(99)70182-4","article-title":"Mesalamine blocks tumor necrosis factor growth inhibition and nuclear factor kappaB activation in mouse colonocytes","volume":"116","author":"Kaiser","year":"1999","journal-title":"Gastroenterology"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20041948","article-title":"Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma","volume":"201","author":"Rousseaux","year":"2005","journal-title":"J Exp Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2016.04.005","article-title":"Complement therapeutic strategies in trauma, hemorrhagic shock and systemic inflammation - closing Pandora\u2019s box","volume":"28","author":"Huber-Lang","year":"2016","journal-title":"Semin Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.smim.2018.02.008","article-title":"The intestinal complement system in inflammatory bowel disease: Shaping intestinal barrier function","volume":"37","author":"Sina","year":"2018","journal-title":"Semin Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00281-011-0290-8","article-title":"Fibrinogen as a key regulator of inflammation in disease","volume":"34","author":"Davalos","year":"2012","journal-title":"Semin Immunopathol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-07-818211","article-title":"The multifaceted role of fibrinogen in tissue injury and inflammation","volume":"133","author":"Luyendyk","year":"2019","journal-title":"Blood"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2017.08.003","article-title":"Regulation of epithelial cell expressed C3 in the intestine - Relevance for the pathophysiology of inflammatory bowel disease","volume":"90","author":"S\u00fcnderhauf","year":"2017","journal-title":"Mol Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1097\/00024382-200005000-00005","article-title":"Interleukin-1beta induces complement component C3 and IL-6 production at the basolateral and apical membranes in a human intestinal epithelial cell line","volume":"13","author":"Moon","year":"2000","journal-title":"Shock (Augusta Ga)"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.151.8.4239","article-title":"Differential cytokine regulation of complement C3, C4, and factor B synthesis in human intestinal epithelial cell line, Caco-2","volume":"151","author":"Andoh","year":"1993","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/cr.2009.139","article-title":"Complement and its role in innate and adaptive immune responses","volume":"20","author":"Dunkelberger","year":"2010","journal-title":"Cell Res"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000056","article-title":"The complement system in inflammatory bowel disease","volume":"20","author":"Jain","year":"2014","journal-title":"Inflammatory Bowel Dis"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21012","article-title":"Role of the C5a receptor (C5aR) in acute and chronic dextran sulfate-induced models of inflammatory bowel disease","volume":"15","author":"Johswich","year":"2009","journal-title":"Inflammatory Bowel Dis"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1200553","article-title":"Complement-dependent injury and protection in a murine model of acute dextran sulfate sodium-induced colitis","volume":"188","author":"Schepp-Berglind","year":"2012","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12464","article-title":"Regulation of the alternative pathway of complement modulates injury and immunity in a chronic model of dextran sulphate sodium-induced colitis","volume":"179","author":"Elvington","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.306853","article-title":"Cross talk pathways between coagulation and inflammation","volume":"118","author":"Foley","year":"2016","journal-title":"Circ Res"},{"key":"B74","doi-asserted-by":"publisher","first-page":"e20191865","DOI":"10.1084\/jem.20191865","article-title":"A critical role for plasminogen in inflammation","volume":"217","author":"Baker","year":"2020","journal-title":"J Exp Med"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell"},{"key":"B76","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41569-022-00735-4","article-title":"The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease","volume":"20","author":"Fang","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1978.tb00374.x","article-title":"Serum ferritin during infection. A longitudinal study","volume":"21","author":"Birgeg\u00e5rd","year":"1978","journal-title":"Scandinavian J Haematol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxx031","article-title":"Hyperferritinemia and inflammation","volume":"29","author":"Kernan","year":"2017","journal-title":"Int Immunol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.yexcr.2005.07.002","article-title":"A physiological model to study iron recycling in macrophages","volume":"310","author":"Delaby","year":"2005","journal-title":"Exp Cell Res"},{"key":"B80","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0016-5085(91)90575-6","article-title":"Expression of class II molecules on intestinal epithelial cells in humans. Differences between normal and inflammatory bowel disease","volume":"100","author":"Mayer","year":"1991","journal-title":"Gastroenterology"},{"key":"B81","doi-asserted-by":"publisher","first-page":"e0265189","DOI":"10.1371\/journal.pone.0265189","article-title":"Profound gene expression changes in the epithelial monolayer of active ulcerative colitis and Crohn\u2019s disease","volume":"17","author":"S\u00e6terstad","year":"2022","journal-title":"PloS One"},{"key":"B82","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.immuni.2019.08.011","article-title":"MHC class II antigen presentation by the intestinal epithelium initiates graft-versus-host disease and is influenced by the microbiota","volume":"51","author":"Koyama","year":"2019","journal-title":"Immunity"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i29.9653","article-title":"Intestinal antigen-presenting cells in mucosal immune homeostasis: crosstalk between dendritic cells, macrophages and B-cells","volume":"20","author":"Mann","year":"2014","journal-title":"World J Gastroenterol"}],"container-title":["Frontiers in Gastroenterology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgstr.2025.1592669\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T11:49:08Z","timestamp":1751456948000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgstr.2025.1592669\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":83,"alternative-id":["10.3389\/fgstr.2025.1592669"],"URL":"https:\/\/doi.org\/10.3389\/fgstr.2025.1592669","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.03.13.25323857","asserted-by":"object"}]},"ISSN":["2813-1169"],"issn-type":[{"value":"2813-1169","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"article-number":"1592669"}}